Hakozaki, Koichi
Aoki, Kazuaki
Kawakita, Fumihiro
Sekijima, Hidehisa
Kotani, Hirokazu
Suzuki, Hidenori https://orcid.org/0000-0002-8555-5448
,
Umeda, Yasuyuki
Tanaka, Katsuhiro
Miura, Yoichi
Kamei, Yusuke
Sano, Takanori
Araki, Tomohiro
Shiba, Masato
Ichikawa, Naoki
Shimizu, Shigetoshi
Tsuchiya, Takuro
Asada, Reona
Suzuki, Hidenori
Toma, Naoki
Yasuda, Ryuta
Kawakita, Fumihiro
Nishikawa, Hirofumi
Kanamaru, Hideki
Kitano, Yotaro
Suzuki, Yume
Ishida, Fujimaro
Fukazawa, Keiji
Tsuda, Kazuhiko
Sato, Yu
Nakajima, Hideki
Hatazaki, Seiji
Hamada, Kazuhide
Nampei, Mai
Miya, Fumitaka
Tanemura, Hiroshi
Fujimoto, Masashi
Funding for this research was provided by:
Mie University
Article History
Received: 28 January 2026
Accepted: 20 April 2026
First Online: 2 June 2026
Declarations
:
: Dr. Suzuki reported personal fees and a research fund from Nxera Pharma outside the submitted work. The other authors declare that they have no conflicts of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the ethical committee of Mie University Hospital (approval number H2023-010).
: Written informed consent was obtained from all patients or their relatives.